newsfilter
← Latest News
GlobeNewswire·

RayzeBio Reports Third Quarter 2023 Financial Results and Provides Corporate Update

SAN DIEGO, Nov. 13, 2023 (GLOBE NEWSWIRE) -- RayzeBio, Inc. (NASDAQ:RYZB), a targeted radiopharmaceutical company developing an innovative pipeline against validated solid tumor targets, today reported financial